Bora CDMO Bora CDMO

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Diclofenac Potassium on PharmaCompass.com

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
14
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • CAPSULE;ORAL - 25MG
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9827197
Y
2026-06-16
22165
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8110606
2029-02-24
U-980
22202
NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8927604
2026-06-16
U-436
22165
ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7884095
2029-02-24
U-1111
22202
NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7759394
Y
Y
2026-06-16
U-436
22165
ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9561200
2029-02-24
U-1482
22202
DICLOFENAC POTASSIUM FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7662858
2029-02-24
U-1035
22202
NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8623920
2029-02-24
U-1482
22202
DICLOFENAC POTASSIUM FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8097651
Y
Y
2026-06-16
U-436
22165
ACUTE TREATMENT OF MIGRAINE ATTACKS WITH OR WITHOUT AURA IN ADULTS
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7939518
2029-02-24
U-980
22202
NONSTEROIDAL ANTI-INFLAMMATORY DRUG INDICATED FOR RELIEF OF MILD TO MODERATE ACUTE PAIN
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY